期刊文献+

银杏内酯注射液联合氯吡格雷对老年脑梗死恢复期患者神经功能及预后的影响 被引量:2

Influence of ginkgolide injection combined with clopidogrel on the neurologic function and prognosis of elderly cerebral infarction convalescence patients
下载PDF
导出
摘要 目的探讨银杏内酯注射液联合氯吡格雷对老年脑梗死恢复期患者神经功能及预后的影响。方法选取雅安市人民医院2015年5月—2017年5月收治的老年脑梗死恢复期患者80例,根据随机数字表法分为对照组和观察组,各40例。对照组给予氯吡格雷治疗,观察组患者在对照组基础上加用银杏内酯注射液治疗,两组患者均持续治疗2周。比较两组患者治疗前后美国国立卫生院卒中量表(NIHSS)评分、预后及不良反应发生情况。结果治疗前,两组患者NIHSS评分比较,差异无统计学意义(P>0.05);治疗后,观察组患者NIHSS评分低于对照组(P<0.05)。观察组患者预后优于对照组(P<0.05)。两组患者不良反应发生率比较,差异无统计学意义(P>0.05)。结论银杏内酯注射液联合氯吡格雷治疗老年脑梗死恢复期患者的临床疗效确切,可有效改善患者神经功能及预后,且安全性较高。 Objective To observe the influence of ginkgolide injection combined with clopidogrel on the neurologic function and prognosis of elderly cerebral infarction convalescence patients.Methods A total of 80 cases of elderly patients with cerebral infarction convalescence were selected from May 2015 to May 2017 in Ya' an People' s Hospital, which were divided into control group and observation group according to random number table method, 40 cases in each group.The control group was treated with clopidogrel alone, the observation group was treated with ginkgolide injection on the basis of control group, both groups were treated for 2 weeks.The NIHSS scores before and after treatment, prognosis and the incidence of adverse reactions were compared between the two groups.Results Before treatment, no significant difference of NIHSS scores was found between the two groups ( P〉0.05 ) ; after treatment, the NIHSS scores in observation group was lower than control group ( P〈0.05 ). The observation group of prognosis was better than control group ( P〈0.05 ) .There was no siginificant difference of the incidence rate of adverse reactions between the two groups ( P〉0.05 ) .Conclusion Ginkgolide injection combined with clopidogrel have an exactly clinical effect in treating elderly cerebral infarction convalescence patients, it can effectively improve the neurologic function and prognosis of patients, and with high safety.
作者 祝莹 康林 罗晓静 ZHU Ying;KANG Lin;LUO Xiao-jing(Department of Geriatric Cadre,Ya' an People' s Hospital,Ya' an 625000,Chin)
出处 《临床合理用药杂志》 2018年第18期3-4,共2页 Chinese Journal of Clinical Rational Drug Use
关键词 脑梗死 老年人 银杏内酯注射液 氯吡格雷 预后 Cerebral infarction Aged Ginkgolide injection Clopidogrel Prognosis
  • 相关文献

参考文献7

二级参考文献75

  • 1郝盼盼,陈玉国,张运.氯吡格雷抵抗相关因素的研究进展[J].心血管病学进展,2009,30(6):991-994. 被引量:21
  • 2贾爱明,谭婧,胡文梅,张策,张红,刘耘.缺血性脑卒中复发的体质因素及中医诱因[J].中国老年学杂志,2014(9):2435-2437. 被引量:41
  • 3Rocca B, Patrono C. Determinants of the interindividual variability in response to antiplatelet drugs [ J ]. J Thromb Haemost ,2005,3 ( 8 ) : 1597-1602.
  • 4Wang TH, Bhatt DL, Topoi EJ. Aspirin and clopidogrel resistance:an emerging clinical entity [ J 3. Eur Heart J, 2006,27 ( 6 ) : 647- 654.
  • 5Oqueli E, Hisock M, Dick R. Clopidogrel resistance [ J ]. Heart Lung Circ ,2007,16 ( 3 ) : 17228.
  • 6Simon T, Verstuyft C, Mary-Krause M, et al. For French Registry of Acute ST-Elevation and Non-ST-ElevationMyocardial Infarction (FAST-MI) Investigators : Genetic determinants of response to clopidogrel and cardiovascular events[ J]. N Engl J Med,2009,360(4) :363-375.
  • 7Par6 G, Mehta SR, Yusuf S, et al. Effects of CYP2C19 genotype on outcomes of clopidogrel treatment [ J ]. N Engl J Med,2010,363(18) :1704-1714.
  • 8Simon T, Verstuyft C, Mary-Krause M, et al. Genetic determinants of response to clopidogrel and cardiovascular events [ J ]. N Engl J Med, 2009,360 (4) : 363-375.
  • 9U. S. Food and Drug Administration. FDA Drug Safety Communication: Reduced effectiveness of plavix "( ~10pi- dogrel) in patients who are poor metabolizers of the drug [ DB/OL]. 2010 [ 2010-03-12 ~. http://www, fda. gov/ Drugs.
  • 10Gurbel PA, Becker RC, Mann KG, et al. Platelet function monitoring in patients with coronary artery disease [ J ]. J Am Coll Cardiol,2007,50(19) :182221834.

共引文献33091

同被引文献7

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部